Compare Enveric Biosciences Inc (ENVB) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Kraft Heinz Co — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Kraft Heinz Co trades at $24.7 (market cap $29.56B). The key difference: Kraft Heinz Co is far larger — about 4767.7× Enveric Biosciences Inc's market cap, and Kraft Heinz Co pays a 6.42% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | KHC | |
|---|---|---|
Market Cap | $6.20M | $29.56B |
Sector | Health | Consumer Staples |
52-Week High | $17.40 | $28.06 |
52-Week Low | $1.27 | $21.21 |
Enterprise Value | $1.30M | $45.88B |
Dividend Yield | — | 6.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.55, down 0.64% with a bullish technical signal despite negative profitability. The company shows promising clinical progress with its lead candidate EB-003, supported by recent FDA guidance and positive preclinical data. While quarterly earnings consistently beat expectations, the company remains unprofitable with negative ROE and ROA. Analyst sentiment is positive with 75% buy ratings.
Investment outlook hinges on successful drug development milestones, with regulatory progress and intellectual property expansion providing catalysts. Key risks include clinical trial outcomes, cash burn from operations, and dependence on financing activities. The stock presents speculative growth potential for risk-tolerant investors focused on biotech innovation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
